Inovio Pharmaceuticals (INO) Change in Cash (2016 - 2026)

Inovio Pharmaceuticals' Change in Cash history spans 16 years, with the latest figure at $7.7 million for Q4 2025.

  • On a quarterly basis, Change in Cash fell 82.54% to $7.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$21.5 million, a 141.82% decrease, with the full-year FY2025 number at -$21.5 million, down 141.82% from a year prior.
  • Change in Cash hit $7.7 million in Q4 2025 for Inovio Pharmaceuticals, down from $12.2 million in the prior quarter.
  • Over the last five years, Change in Cash for INO hit a ceiling of $44.1 million in Q4 2024 and a floor of -$167.1 million in Q1 2021.
  • Historically, Change in Cash has averaged -$10.3 million across 5 years, with a median of -$8.3 million in 2022.
  • Biggest five-year swings in Change in Cash: soared 1081.94% in 2024 and later tumbled 589.47% in 2025.
  • Tracing INO's Change in Cash over 5 years: stood at $3.2 million in 2021, then skyrocketed by 660.08% to $24.3 million in 2022, then tumbled by 118.46% to -$4.5 million in 2023, then soared by 1081.94% to $44.1 million in 2024, then crashed by 82.54% to $7.7 million in 2025.
  • Business Quant data shows Change in Cash for INO at $7.7 million in Q4 2025, $12.2 million in Q3 2025, and -$15.6 million in Q2 2025.